Clinical trial

Efficacy Study of Cardizem in Pulmonary Arterial Hypertension

NCT01645826

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2012-07-01

PhaseNA

Study timeline

Study start (unknown)2012-07-01Date precision: month

Registry last updated2018-11-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Idiopathic Pulmonary Arterial Hypertensionunresolved

Primary Pulmonary Hypertensionunresolved

Pulmonary Arterial Hypertensionunresolved

Familial Primary Pulmonary Hypertensionunresolved

Interventions

Diltiazem HydrochlorideDRUG · verified · RxNorm: diltiazem hydrochloride

Sponsors & collaborators

University of South Floridalead sponsor

Mapped research locations

TampaFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01645826 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.